Showing results (5381-5390 of 25,889) with videos related to

Sort By:
Pageof 2,589
Anticancer Research|April 4, 2008
Prognostic factors in patients with locally advanced (unresectable) or metastatic pancreatic adenocarcinoma: a retrospective analysisNikitas Papadoniou, Christos Kosmas, Kostadinos Gennatas, et al.
Anticancer Research|April 4, 2008
Laryngeal carcinoma recurrence rate and disease-free interval are related to CD105 expression but not to vascular endothelial growth factor 2 (Flk-1/Kdr) expressionGino Marioni, Luciano Giacomelli, Emiliano D'Alessandro, et al.
Anticancer Research|January 30, 2008
Atrial natriuretic peptide and long acting natriuretic peptide inhibit MEK 1/2 activation in human prostate cancer cellsYing Sun, Ehrentraud J Eichelbaum, Hai Wang, et al.
Anticancer Research|January 30, 2008
Heterozygosity for interleukin-18 -607 A/C polymorphism is associated with risk for colorectal cancerNikolaos Nikiteas, Athanasios Yannopoulos, Agapi Chatzitheofylaktou, et al.
Anticancer Research|January 30, 2008
Cytostatic murine B16 cell-pulsed dendritic cells induce effective protection against melanoma in miceDebora Joseph-Pietras, Annie Carlier, Claudie Madoulet, et al.
Anticancer Research|January 30, 2008
Intranuclear nucleolin distribution during cell cycle progression in human invasive ductal breast carcinomas in relation to estrogen receptor statusMarek Masiuk, Elzbieta Urasinska, Wenancjusz Domagala
Anticancer Research|January 30, 2008
The interleukin-18 -607A/C polymorphism is not associated with risk for oral cancerEleftherios Vairaktaris, Zoe Charalambus Serefoglou, Christos Yapijakis, et al.
Anticancer Research|January 30, 2008
Antitumor activity of the somatostatin structural derivative (TT-232), against mouse and human melanoma tumor modelsM Tejeda, D Gaál, L Hullán, et al.
Anticancer Research|January 30, 2008
Tumor-specific cytotoxic activity and type of cell death induced by 4-trifluoromethylimidazoles in human oral squamous cell carcinoma cell linesFumihiro Takekawa, Tatsuhito Nagumo, Satoru Shintani, et al.
Anticancer Research|January 30, 2008
Hepatic intra-arterial interferon alpha 2b-based immunotherapy combined with 5-fluorouracil (5-FU)-based systemic chemotherapy for patients with hepatocellular carcinoma (HCC) not responsive and/or not eligible for conventional treatments: a pilot studyFelice Vito Vitale, Placido Romeo, Fabio Vasta, et al.
Pageof 2,589